jdm

Journal of Diabetes & Metabolism

ISSN - 2155-6156

Opinion - (2023) Volume 14, Issue 7

Depression and Diabetes

Nancy Barnes*
 
*Correspondence: Nancy Barnes, Tracy Barnes, Director, Clinical Practice Guidelines (Diabetes Canada), Canada, Email:

Author info »

Introduction

Diabetes and mental health are intricately linked, forming a bidirectional relationship that can significantly impact an individual's overall well-being. Managing diabetes, whether it is type 1 or type 2, requires a complex daily regimen that includes blood glucose monitoring, medication administration, dietary adjustments, and regular physical activity [1]. The stress and burden of diabetes management can take a toll on mental health, leading to feelings of anxiety, depression, and emotional distress. Additionally, individuals with pre-existing mental health conditions may find it challenging to cope with the demands of diabetes management, further complicating their diabetes outcomes [2]. On the other hand, fluctuations in blood glucose levels can also influence mood and cognitive function, affecting a person's mental health. Addressing the interconnectedness of diabetes and mental health is crucial for optimizing diabetes self-management and overall quality of life. Healthcare providers need to adopt a holistic approach, providing support not only for the physical aspects of diabetes but also addressing the emotional and psychological well-being of individuals living with this chronic condition [3]. By recognizing and addressing the psychological aspects of diabetes, healthcare professionals can help empower patients to better cope with the challenges of diabetes management, ultimately improving both their diabetes outcomes and mental health [4].

Discussion

The intricate relationship between diabetes and mental health has significant implications for the overall well-being and quality of life of individuals living with diabetes. This bidirectional association between the two conditions underscores the importance of adopting a holistic approach to diabetes management that addresses both the physical and psychological aspects of the disease [5].

Impact of diabetes on mental health: The daily demands of diabetes management can be overwhelming and stressful for many individuals. The constant monitoring of blood glucose levels, adherence to medication regimens, and dietary restrictions can lead to feelings of frustration, anxiety, and burnout [6]. The fear of diabetes-related complications and the burden of self-care can also contribute to depressive symptoms and emotional distress. Psychological factors and diabetes outcomes: Mental health conditions such as depression and anxiety can have a profound impact on diabetes outcomes. Studies have shown that individuals with diabetes and co-existing mental health conditions are at higher risk of poor glycaemic control, increased hospitalizations, and diabetes-related complications [7]. Psychological factors may also influence treatment adherence and self-management behaviors, affecting overall diabetes management.

Impact of blood glucose fluctuations on mood: Fluctuations in blood glucose levels can have acute effects on mood and cognitive function. Hypoglycaemic episodes, characterized by low blood sugar levels, can cause symptoms like irritability, confusion, and anxiety [8]. On the other hand, hyperglycaemia, characterized by high blood sugar levels, may lead to fatigue, difficulty concentrating, and feelings of irritability.

Stigma and mental health: Stigma associated with diabetes can also have adverse effects on mental health. People with diabetes may experience feelings of shame or blame, particularly if they perceive their condition as a result of lifestyle choices. Addressing diabetes-related stigma is crucial to promoting mental well-being and empowering individuals to effectively manage their condition [9, 10].

Importance of integrated care: Recognizing the interconnectedness of diabetes and mental health, integrated care models are gaining prominence. These models involve collaboration between diabetes care providers and mental health professionals to provide comprehensive support to individuals with diabetes. Integrated care can improve treatment adherence, glycaemic control, and overall mental well-being [11].

Patient education and support: Patient education plays a vital role in empowering individuals to cope with the psychological impact of diabetes. Providing patients with resources and support groups that address mental health concerns can help normalize the emotional challenges associated with diabetes. Informed patients are better equipped to engage in self-care and seek appropriate help when needed [12].

Screening for mental health conditions: Routine screening for mental health conditions should be an integral part of diabetes care. Early identification of depression, anxiety, and other mental health issues allows for timely intervention and support, potentially preventing further psychological distress [13- 15].

Acknowledgement

None

Conflict of Interest

None

References

  1. Tsiachristas A, Dikkers C, Boland MRS, Rutten-van Molken MPMH (2013) Exploring payment schemes used to promote integrated chronic care in Europe. Health Policy 113(3): 296-304.
  2. Indexed at, Google Scholar, Crossref

  3. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, et al. (1998) Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 47: 1643-1649.
  4. Indexed at, Google Scholar, Crossref

  5. Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
  6. Indexed at, Google Scholar, Crossref

  7. Abdul-Ghani MA, DeFronzo RA (2009) Pathophysiology of prediabetes. Curr Diab Rep 9: 193-199.
  8. Indexed at, Google Scholar, Crossref

  9. Ausk KJ, Boyko EJ, Ioannou GN (2010) Insulin resistance predicts mortality in nondiabetic individuals in the U.S. Diabetes care 33:1179-1185.
  10. Indexed at, Google Scholar, Crossref

  11. Ceriello A, Monnier L, Owens D (2019) Glycaemic variability in diabetes: clinical and therapeutic implications. Lancet Diabetes Endocrinol 7: 221-230
  12. Indexed at, Google Scholar, Crossref

  13. Home P (2005) Contributions of basal and post-prandial hyperglycaemia to micro- and macrovascular complications in people with type 2 diabetes. Curr Med Res Opin 21: 989-998.
  14. Indexed at, Google Scholar, Crossref

  15. Association AD (2020) Improving care and promoting health in populations: standards of medical care in diabetes-2020. Diabetes Care 43: 7-13.
  16. Indexed at, Google Scholar, Crossref

  17. Watt GP, De La Cerda I, Pan JJ, Fallon MB, Beretta L, et al. (2020) Elevated glycated hemoglobin is associated with liver fibrosis, as assessed by elastography, in a population-based study of Mexican Americans. Hepatol Commun 4: 1793-1801.
  18. Indexed at, Google Scholar, Crossref

  19. Głowinska-Olszewska B, Borysewicz-Sańczyk H, Sawicka B, Klonowska B, Charemska D, et al. (2020) Does Hashimoto's thyroiditis increase the risk of cardiovascular disease in young Type 1 diabetic patients? Front Endocrinol (Lausanne) 11: 431.
  20. Indexed at, Google Scholar, Crossref

  21. Ogarek N, Mrówka A, Jarosz-Chobot P (2021) Thyroid diseases - ally or enemy of type 1 diabetes in children and adolescents? Pediatr Endocrinol Diabetes Metab 27: 117-122.
  22. Indexed at, Google Scholar, Crossref

  23. Kilpatrick ES, Rigby AS, Atkin SL (2008) A1c variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial. Diabetes Care 31: 2198-2202.
  24. Indexed at, Google Scholar, Crossref

  25. Cavalot F (2013) Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes. Diabetes Obes Metab 15: 3-8.
  26. Indexed at, Google Scholar, Crossref

  27. Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, et al. (2015) Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis. Diabetes Care 38: 2354-2369.
  28. Indexed at, Google Scholar, Crossref

  29. Sugawara A, Kawai K, Motohashi S (2012) HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia 55: 2128-2131.
  30. Indexed at, Google Scholar, Crossref

Author Info

Nancy Barnes*
 
Tracy Barnes, Director, Clinical Practice Guidelines (Diabetes Canada), Canada
 

Citation: Nancy Barnes. Depression and Diabetes. J Diabetes Metab, 2023, 14(7): 1027.

Received: 30-Jun-2023, Manuscript No. jdm-23-25893; Editor assigned: 03-Jul-2023, Pre QC No. jdm-23-25893(PQ); Reviewed: 17-Jul-2023, QC No. jdm-23-25893; Revised: 24-Jul-2023, Manuscript No. jdm-23-25893(R); Published: 31-Jul-2023, DOI: 10.35248/2155-6156.10001027

Copyright: © 2023 Barnes N. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.